• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Candriam Equities L Biotechnology

+ Add to Watchlist

DEXEBTN:LX

305.65 USD 2.77 0.91%

As of 00:59:30 ET on 07/22/2014.

Snapshot for Candriam Equities L Biotechnology (DEXEBTN)

Year To Date: +7.56% 3-Month: +11.69% 3-Year: +27.76% 52-Week Range: 236.47 - 335.17
1-Month: -3.38% 1-Year: +21.96% 5-Year: +26.19% Beta vs BTK: 0.90

Mutual Fund Chart for DEXEBTN

No chart data available.
  • DEXEBTN:LX 302.88
  • 1M
  • 1Y
Interactive DEXEBTN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DEXEBTN

Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.

Inception Date: 08-23-2002 Telephone: 352-254-3431
Managers: RUDI VAN DEN EYNDE
Web Site: www.candriam.com

Fundamentals for DEXEBTN

NAV (on 2014-07-21) 302.88
Assets (M) (on 2014-07-21) 569.12
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for DEXEBTN

No dividends reported

Fees & Expenses for DEXEBTN

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 2.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 2.23

Top Fund Holdings for DEXEBTN

Filing Date: 05/30/2014
Name Position Value % of Total
Gilead Sciences Inc 611,000 49,619,310 8.921%
Celgene Corp 600,000 45,909,000 8.254%
Amgen Inc 343,000 39,784,570 7.153%
Biogen Idec Inc 117,000 37,366,290 6.718%
Alexion Pharmaceuticals Inc 190,000 31,600,800 5.682%
Regeneron Pharmaceuticals Inc 75,000 23,022,000 4.139%
Illumina Inc 112,000 17,724,000 3.187%
Vertex Pharmaceuticals Inc 200,000 14,452,000 2.598%
Incyte Corp Ltd 270,000 13,378,500 2.405%
BioMarin Pharmaceutical Inc 208,000 12,055,680 2.167%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil